Pharmacology, Toxicology and Pharmaceutical Science
Bexarotene
100%
Retinoid X Receptor
70%
Receptor Agonist
37%
Malignant Neoplasm
29%
Benzoic Acid
24%
Cutaneous T Cell Lymphoma
23%
Naphthalene
19%
Side Effect
19%
Receptor
13%
Cell Nucleus Receptor
13%
Immunocompromised Patient
12%
Nicotinic Acid
12%
Pharmacotherapy
12%
Mycosis
12%
Triacylglycerol
11%
Alzheimer's Disease
11%
Disease
10%
Retinoid
10%
Mutagenicity
8%
Cell Culture
8%
Hypothyroidism
7%
Retinoic Acid Receptor
7%
Allyl
6%
Lung Cancer
6%
Synthetase
6%
Curcumin
6%
Capsaicinoids
6%
Saccharomyces cerevisiae
6%
Breast Cancer
6%
Escherichia coli
6%
Mutagenic Agent
6%
Adenosine Triphosphate
6%
Tumor Growth
6%
Degenerative Disease
6%
Parkinson's Disease
6%
EC50
5%
Sterol Regulatory Element Binding Protein
5%
Keyphrases
Bexarotene
67%
Retinoid X Receptor
60%
Receptor Agonist
35%
Naphthyl
18%
Cutaneous T-cell Lymphoma
14%
Ethynyl
12%
Extracellular Calcium
12%
Evaluation Model
12%
Benzoic Acid
12%
Biological Evaluation
12%
Synthetic Evaluation
12%
Selective Agonist
12%
Alzheimer's Disease
11%
Gene Expression
9%
Mathematical Modeling
9%
Rexinoids
9%
High Affinity
8%
Immune-compromised Patients
8%
Aided Design
8%
Novel Analogues
7%
Parkinson's Disease
6%
Neurodegenerative Diseases
6%
Hypothyroidism
6%
Susceptible Strain
6%
Back mutation
6%
Novel Genes
6%
FoF1-ATP Synthase
6%
Drug Treatment
6%
Amino
6%
Negatively Regulate
6%
EcoPlate
6%
Community-level Physiological Profile
6%
Isochroman
6%
Therapeutic Agents
6%
Crime Evidence
6%
Tetrahydro-1
6%
Calmodulin Kinase
6%
RXR Agonist
6%
Temperature-sensitive mutant
6%
Escherichia Coli
6%
Purification Characterization
6%
Tongue Map
6%
Peroxisomal
6%
Cancer Therapeutics
6%
Immune-compromised
6%
FUN-1
6%
Vacuolar Protein Sorting
6%
Vital Dye Staining
6%
Nicotinic Acid
6%
Tetrahydrocurcumin
6%
